Drug-Eluting Stents Clear Safety Hurdles Associated With Radiation - Serruys
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials exploring the use of drug-eluting stents to treat in-stent restenosis have avoided some of the initial complications raised by intravascular brachytherapy procedures, according to the lead investigator for trials evaluating Johnson & Johnson/Cordis' Sirolimus-coated BxVelocity stent.